107 related articles for article (PubMed ID: 8460096)
1. Inhibition of growth of a transplanted rat pancreatic acinar carcinoma with CCK-8.
Karsenty L; Hajri A; Aprahamian M; Garaud JC; Doffoël M; Damgé C
Pancreas; 1993 Mar; 8(2):204-11. PubMed ID: 8460096
[TBL] [Abstract][Full Text] [Related]
2. Effects of cholecystokinin octapeptide on a pancreatic acinar carcinoma in the rat.
Hajri A; Damgé C
Pharm Res; 1998 Nov; 15(11):1767-74. PubMed ID: 9834001
[TBL] [Abstract][Full Text] [Related]
3. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization.
Zhou W; Povoski SP; Longnecker DS; Bell RH
Cancer Res; 1992 Dec; 52(24):6905-11. PubMed ID: 1458479
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH
Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719
[TBL] [Abstract][Full Text] [Related]
5. Autoradiographic localization of cholecystokinin (CCK) receptor expression during the development of azaserine-induced rat pancreatic carcinoma.
Tsuei BJ; Povoski SP; Zhou W; Bell RH
Pancreas; 1996 Nov; 13(4):401-6. PubMed ID: 8899801
[TBL] [Abstract][Full Text] [Related]
6. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
[TBL] [Abstract][Full Text] [Related]
7. The effect of intermittent injections of CCK-8S and the CCK-A receptor antagonist devazepide on cell proliferation in exocrine rat pancreas.
Ohlsson B; Borg K; Rehfeld JF; Ihse I; Axelson J
Int J Pancreatol; 1998 Dec; 24(3):211-8. PubMed ID: 9873956
[TBL] [Abstract][Full Text] [Related]
8. Effect of CCK receptor antagonist on growth of pancreatic adenocarcinoma.
Shivaram S; Crist KA; Chaudhuri B; Mucci SJ; Chaudhuri PK
J Surg Res; 1992 Sep; 53(3):234-7. PubMed ID: 1528048
[TBL] [Abstract][Full Text] [Related]
9. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Digestion; 1989; 42(2):61-9. PubMed ID: 2475379
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of messenger RNA for cholecystokinin-A receptor and novel expression of messenger RNA for gastrin (cholecystokinin-B) receptor in azaserine-induced rat pancreatic carcinoma.
Zhou W; Povoski SP; Bell RH
Carcinogenesis; 1993 Oct; 14(10):2189-92. PubMed ID: 8222074
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
Niederau C; Liddle RA; Williams JA; Grendell JH
Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
[TBL] [Abstract][Full Text] [Related]
12. Effect of proglumide on rat pancreatic growth.
Yamaguchi T; Tabata K; Johnson LR
Am J Physiol; 1985 Aug; 249(2 Pt 1):G294-8. PubMed ID: 2411150
[TBL] [Abstract][Full Text] [Related]
13. Effect of a novel cholecystokinin receptor antagonist, FK480, administered intraduodenally, on pancreatic secretion in rats.
Moriyoshi Y; Shiratori K; Takeuchi T; Watanabe S
Pancreas; 1995 Apr; 10(3):295-300. PubMed ID: 7542771
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent pancreatotrophic effect of cholecystokinin-octapeptide in the rat: the influence of starvation.
Nagy I; Lászik Z; Mohácsi G
Pharmacol Res; 1998 Apr; 37(4):309-19. PubMed ID: 9634648
[TBL] [Abstract][Full Text] [Related]
15. The effect of CR 1409, a potent CCK receptor antagonist, on basal and stimulated pancreatic secretion in rat.
Takács T; Nagy I; Pap A; Varró V
Pancreas; 1990; 5(1):60-4. PubMed ID: 2293712
[TBL] [Abstract][Full Text] [Related]
16. Both low- and high-affinity CCK receptor states mediate trophic effects on rat pancreatic acinar cells.
Hoshi H; Logsdon CD
Am J Physiol; 1993 Dec; 265(6 Pt 1):G1177-81. PubMed ID: 8279569
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of the trophic actions of bombesin on the pancreas.
Upp JR; Poston GJ; MacLellan DG; Townsend CM; Barranco SC; Thompson JC
Pancreas; 1988; 3(2):193-8. PubMed ID: 2453876
[TBL] [Abstract][Full Text] [Related]
18. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.
Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB
Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631
[TBL] [Abstract][Full Text] [Related]
19. Temporal expression of the gastrin (CCK-B) receptor during azaserine-induced pancreatic carcinogenesis.
Povoski SP; Zhou W; Longnecker DS; Bell RH
Pancreas; 1993 Sep; 8(5):615-21. PubMed ID: 8302799
[TBL] [Abstract][Full Text] [Related]
20. The cholecystokinin receptor antagonist CR1409 increases plasma cholecystokinin in rats.
Jansen JB; de Jong AJ; Lamers CB
Regul Pept; 1989 Feb; 24(2):209-13. PubMed ID: 2922496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]